Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study

Autor: H. Tillaut, Jonathan Roux, S. Leblanc, E. Le Page, Emmanuelle Leray

Publikováno v: Revue Neurologique
Revue Neurologique, Elsevier Masson, 2021, 177 (10), pp.1250-1261. ⟨10.1016/j.neurol.2021.04.006⟩
Revue Neurologique, 2021, 177 (10), pp.1250-1261. ⟨10.1016/j.neurol.2021.04.006⟩

Background Most data regarding the use of disease-modifying therapies (DMTs) in multiple sclerosis (MS) comes from clinical series or regional databases that have a risk of recruitment bias. French health administrative data offers the significant ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51781ca47c6d545b7e01179dad44341c
https://hal.ehesp.fr/hal-03312766

First national results of the evaluation of the neonatal hearing loss screening programme in France

Autor: Goulet, H Tillaut, A Doncarli

Publikováno v: European Journal of Public Health. 29

Background The French newborn hearing screening programme set up in 2014 aims to identify affected children as early as possible to allow appropriate care. Our goal was to evaluate the implementation of this programme at the national level. Methods T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9351e40d7770ff0513633a6d53e8b61f
https://doi.org/10.1093/eurpub/ckz186.188

Travel-associated and autochthonous Zika virus infection in mainland France, 1 January to 15 July 2016

Autor: A, Septfons, I, Leparc-Goffart, E, Couturier, F, Franke, J, Deniau, A, Balestier, A, Guinard, G, Heuzé, A H, Liebert, A, Mailles, J R, Ndong, I, Poujol, S, Raguet, C, Rousseau, A, Saidouni-Oulebsir, C, Six, M, Subiros, V, Servas, E, Terrien, H, Tillaut, D, Viriot, M, Watrin, K, Wyndels, H, Noel, M C, Paty, H, De Valk

Publikováno v: Eurosurveillance

During summer 2016, all the conditions for local mosquito-borne transmission of Zika virus (ZIKV) are met in mainland France: a competent vector, Aedes albopictus, a large number of travellers returning from ZIKV-affected areas, and an immunologicall

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150693e3607717af55748b3af1bc9afe
https://pubmed.ncbi.nlm.nih.gov/27542120

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.